All content on this website is provided for educational and research purposes only. It does not constitute medical advice or treatment. This article discusses biological mechanisms also observed in laboratory and preclinical research models, so no clinical efficacy or safety for human use is implied. The substances discussed, which are not registered medicines, are not intended for use in humans or animals.

SHLP-6 peptide

SHLP-6 (Small Humanin-Like Peptide 6) is a naturally occurring peptide encoded by mitochondrial DNA. It belongs to a group of signaling molecules known as mitochondria-derived peptides (MDPs), which are involved in communication between mitochondria and the rest of the cell.

Small Humanin-Like Peptide 6 was identified during research exploring small peptides encoded within the mitochondrial genome that may influence biological processes related to cellular metabolism, aging, and mitochondrial function.

Because of its association with mitochondrial signaling pathways, SHLP-6 has been studied in experimental research related to energy metabolism, cellular stress responses, and age-related biological processes.

Although SHLP-6 peptide occurs naturally in the human body, synthetic forms used in research are considered experimental compounds and have not been approved as pharmaceutical medications.

How SHLP-6 peptide works

SHLP-6 has been investigated for its role in mitochondrial signaling and metabolic regulation. Experimental research suggests that mitochondria-derived peptides such as SHLP-6 may:

  • participate in communication between mitochondria and the cell nucleus

  • influence pathways related to cellular metabolism and energy balance

  • affect mechanisms involved in mitochondrial stress responses

  • interact with signaling pathways that regulate cell survival and apoptosis

Because mitochondria play a central role in cellular energy production and metabolic regulation, peptides encoded by mitochondrial DNA are being studied for their potential role in aging biology and metabolic health.

However, the precise biological mechanisms of SHLP-6 remain under active investigation.

Clinical trials and evidence

Research involving SHLP-6 peptide has primarily been conducted in laboratory studies and cellular experiments examining mitochondrial signaling pathways. Experimental studies have explored:

  • the biological role of mitochondria-derived peptides in cellular metabolism

  • molecular mechanisms related to mitochondrial stress responses

  • potential links between mitochondrial peptides and aging-related cellular processes

While these studies have provided insights into mitochondrial signaling, SHLP-6 itself has not undergone extensive clinical trials in humans, and most available information comes from preclinical research.

Further studies are needed to determine whether these findings could translate into future therapeutic applications.

Possible side effects of SHLP-6:

Because SHLP-6 peptide has primarily been studied in experimental settings, its complete safety profile in humans has not been fully established. Possible or theoretical side effects may include:

  • headache

  • fatigue

  • mild metabolic changes

  • injection site reactions

Further research is required to better understand the long-term safety and potential risks associated with experimental use of this peptide.

SHLP-6 is a naturally occurring mitochondria-derived peptide studied primarily in research related to mitochondrial biology, metabolism, and aging. Synthetic forms used in experimental settings are considered investigational compounds and are not approved as prescription medications by major regulatory authorities. Scientific research involving such compounds should be conducted with appropriate safety precautions and in accordance with applicable laws and regulations in the relevant country.

The purpose of this website is to provide clear, evidence-based information about biologically active compounds often discussed in research, metabolic health, and biohacking communities. The information presented here is educational and should not be considered medical advice.

SHLP-6
Action: Mitochondrial signaling | Category: mitochondrial peptide
Experimental dosage: 100-300 mcg | Frequency: every day | Timing: freely | Cycle on: 4-6 weeks — Route: subcutaneous (SC). Stop rules: hold and seek medical advice if moderate/severe adverse effects occur (e.g., escalating nausea/vomiting, dizziness, palpitations, significant blood pressure changes, severe injection‑site reactions, allergic symptoms) or if there is no clear ‘return‑to‑baseline’ window between doses. | Cycle off: 4 weeks
Effectiveness: ■■▢▢▢ | Safety: ■■▢▢▢

Related peptides

Peptides from the same functional group:Humanin, MOTS-C, NAD+, SHLP-2, SS-31 (Elamipretide)

Our peptides database

5-Amino-1MQ | AICAR peptide | AOD9604 peptide | Arg-BPC-157 peptide | BPC-157 peptide | CagriSema | Cerebrolysin peptide | CJC-1295 NO DAC peptide | CJC-1295 with DAC peptide | Cortagen peptide | Dihexa peptide | DSIP peptide (Delta Sleep-Inducing Peptide) | Dulaglutide peptide | Epithalon peptide | Exenatide peptide | Follistatin 315 peptide | Follistatin 344 peptide | FOXO4-DRI peptide | GHK-Cu peptide | GHRP-2 peptide | GHRP-6 peptide | Hexarelin peptide | HGH Fragment 176-191 | Humanin peptide | IGF-1 LR3 peptide | Ipamorelin CJC-1295 NO DAC | Ipamorelin peptide | Kisspeptin peptide | KPV peptide | L-Carnitine | Liraglutide peptide | Livagen peptide | LL-37 peptide | Matrixyl peptide | Mazdutide peptide | Melanotan II peptide | Melanotan peptide | MGF peptide (Mechano Growth Factor peptide) | MOD GRF 1-29 | MOTS-C peptide | NAD+ coenzime (Nicotinamide Adenine Dinucleotide) | Oxytocin peptide | P21 peptide | PEG-MGF peptide | Pinealon peptide | PT-141 peptide (Bremelanotide) | PTD-DBM peptide | Retatrutide | Selank peptide | Semaglutide | Semax peptide | Sermorelin peptide | SHLP-2 peptide | SHLP-6 peptide | Somatropin peptide | SS-31 peptide (Elamipretide) | TB-500 peptide | Tesamorelin peptide | Thymosin Alpha 1 peptide | Thymosin beta 4 peptide | Thymosin β10 peptide | Thymulin peptide | Tirzepatide | Vilon peptide
Tagged